Zobrazeno 1 - 10
of 60
pro vyhledávání: '"G. Gurrieri"'
Publikováno v:
European Psychiatry. 24:41-46
ObjectiveMany studies have enlightened the relevance of deepening our knowledge of suicidal ideation among adolescents. However, research has given insufficient attention to the impact of time perspective on suicidal ideation: the present study confi
Publikováno v:
American journal of respiratory and critical care medicine. 155(1)
We previously demonstrated that broxaterol enhanced recovery of fatigued canine diaphragm. The aim of this study was to compare the inotropic effects of salbutamol and broxaterol on fatigued canine diaphragm. Low-frequency fatigue was induced in 14 m
Publikováno v:
The European respiratory journal. 6(3)
Broxaterol, a new selective beta 2-agonist, has been shown to exert inotropic effects on both fresh and fatigued canine diaphragm. We evaluated the effect of broxaterol on the activation and force output of the respiratory muscles in patients with ch
Publikováno v:
International journal of clinical pharmacology, therapy, and toxicology. 30(10)
To investigate the beta 2-receptor selectivity of a new beta 2-adrenoceptor agonist, broxaterol, we compared the respiratory and cardiovascular effects of this compound with those of terbutaline and placebo. Twelve asthmatic patients were evaluated i
Autor:
C, Tantucci, B, Burni, M L, Dottorini, M, Malerba, F, Peccini, G, Gurrieri, C A, Sorbini, V, Grassi
Publikováno v:
International journal of clinical pharmacology research. 10(3)
The ventilatory and gas-exchange effects of broxaterol, a new selective beta 2-adrenoceptor agonist, were investigated in ten asthmatics following intravenous administration of a single dose of 200 mcg. Broxaterol elicited a prompt and marked broncho
Autor:
A, Petraglia, M, Scarpitta, D, Ansalone, G, Gurrieri, V, Galzerano, R C, Calvanese, S, Federico, A, Zinno
Publikováno v:
International journal of clinical pharmacology research. 10(5)
Drugs that stimulate adrenergic receptors are expected to affect glucose and lipid metabolism. Therefore, it was deemed to be of interest to assess whether the new selective beta 2-adrenoceptor agonist, broxaterol, exerts any metabolic effect. Broxat
Autor:
Neil Schachter, Robert H. Israel, Michael C. Kallay, Dario Olivieri, A. Flemale, Amund Gulsvik, A. Foresi, Robert H. Poe, Stavros H. Constantopoulos, Andreas Myking, I. Perlot, Theodore J. Witek, B. Guillot, Gregory Elliott, Giuseppe Maria Corbo, J.J. Pocidalo, A. Cuomo, H.M. Moutsopoulos, P. Aubas, Salvatore Valente, A. Lurie, G. Gurrieri, D. Theven, Elsa Skaarland, F.B. Michel, Donald W. Greenblatt, A. Chetta, James M. Kohan, M.B. Brun-Pascaud, Edward Stark, A.A. Drosos, P. Chanez, Odd Mørkve, Susan Rathbun, Ph. Gris, J.-P. Delmez, Thomas V. Colby, Robert O. Crapo, Tracy Hill, C. Mion, G. Garavaldi, J.-P. Dierckx, Ph. Godard, Lodve Stangeland, G. Mourad, M. Fay, Andrew P. Andonopoulos
Publikováno v:
Respiration. 53:I-V
Publikováno v:
Respiration. 53:220-224
In order to determine the bronchodilating activity and safety of two beta-2-receptor agonists, broxaterol and procaterol, compared with a placebo, 12 patients with reversible airway obstruction were tested in a double-blind cross-over study. The drug
Publikováno v:
Pathologica. 81(1073)
There are at least four different types of Oro-facial-digital syndromes. The features of type II are bilateral polydactyly of hands, peculiar face with normal skin, hair, and intelligence. It is due to an autosomal recessive gene. We report a case of